introduct
viral
respiratori
tract
infect
vrti
common
infect
worldwid
repres
major
public
health
concern
noninfluenza
respiratori
virus
caus
infect
age
group
major
contribut
factor
morbid
mortal
diseas
sever
rang
mild
common
coldlik
ill
sever
lifethreaten
respiratori
tract
infect
burden
noninfluenza
vrti
often
pronounc
individu
chronic
comorbid
clinic
risk
factor
moreov
estim
million
noninfluenza
vrti
occur
annual
unit
state
result
combin
direct
indirect
cost
billion
past
signific
proport
respiratori
tract
diseas
could
attribut
specif
pathogen
advent
molecular
detect
genotyp
techniqu
substanti
increas
recognit
sever
newli
identifi
noninfluenza
respiratori
virus
involv
diseas
potenti
pathogen
includ
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
adenoviru
type
human
rhinoviru
speci
c
rvc
human
bocavirus
diagnost
test
virus
import
mani
sign
symptom
infect
overlap
virus
influenza
would
otherwis
ascrib
case
influenzalik
ill
without
etiolog
assess
coronavirus
ubiquit
worldwid
associ
rel
mild
respiratori
diseas
eg
common
cold
emerg
sarscov
china
sar
epidem
spread
countri
infect
peopl
casefat
rate
approxim
howev
addit
case
document
sinc
nearli
year
later
anoth
virul
coronaviru
merscov
emerg
index
case
merscov
occur
saudi
arabia
june
novemb
laboratoryconfirm
case
death
report
countri
fig
adenovirusassoci
respiratori
diseas
often
associ
speci
b
c
serotyp
associ
outbreak
acut
febril
respiratori
ill
particularli
militari
traine
vaccin
adenovirus
avail
militari
recruit
decreas
burden
adenovirusassoci
acut
respiratori
diseas
ard
popul
vaccin
effort
adenoviru
reportedli
infect
traine
caus
pneumonia
case
militari
train
camp
speci
b
emerg
new
sourc
ard
militari
traine
gener
public
ard
first
describ
dutch
militari
recruit
rare
report
sinc
major
outbreak
militari
train
center
unit
state
occur
known
caus
potenti
sever
acut
respiratori
ill
militari
civilian
individu
rvc
human
bocaviru
type
recent
identifi
molecular
method
found
preval
wide
distribut
geograph
frequent
associ
sever
respiratori
diseas
follow
primari
infect
particularli
young
children
rvc
also
exacerb
factor
asthma
chronic
obstruct
airway
diseas
serolog
quantit
polymeras
chain
reaction
pcr
analys
provid
compel
evid
etiolog
agent
sever
form
respiratori
tract
diseas
review
detail
virolog
epidemiolog
clinic
diagnost
aspect
viral
speci
coronavirus
envelop
singlestrand
positivesens
rna
virus
rel
larg
genom
kb
spike
glycoprotein
protrud
virion
give
viru
characterist
crownlik
ie
corona
appear
electron
microscopi
coronavirus
describ
infect
human
belong
alphacoronaviru
betacoronaviru
genera
cov
alphacoronavirus
wherea
sar
mer
betacoronavirus
identifi
viral
cultur
describ
sar
epidem
detect
nucleic
acid
method
howev
studi
shown
virus
unlik
sarscov
merscov
recent
introduc
human
popul
human
cov
cultur
vitro
except
adenovirus
larg
nm
doublestrand
dna
virus
nonenvelop
viru
adenoviru
stabl
environ
somewhat
resist
deterg
advers
environment
condit
linear
dna
genom
associ
core
protein
termin
protein
coval
attach
end
adenoviru
icosahedr
capsid
form
structur
protein
includ
hexon
penton
base
fiber
fiber
protein
spikelik
project
termin
knob
interact
host
cell
receptor
along
penton
base
speci
ag
adenoviru
group
oncogen
potenti
rodent
hemagglutin
properti
dna
homolog
use
serum
neutral
andor
hexon
gene
sequenc
speci
character
serotyp
serotyp
describ
caus
varieti
clinic
syndrom
tabl
seri
studi
publish
describ
novel
clade
rv
detect
respiratori
specimen
patient
acut
respiratori
ill
asthma
influenzalik
ill
genet
distinct
exist
rhinovirus
subsequ
design
rvc
rv
divid
speci
base
phylogenet
analys
wellcharacter
speci
b
novel
rvc
speci
although
newli
describ
indic
rvc
circul
decad
seem
rvc
went
undetect
year
propag
use
tradit
virusisol
method
histor
rv
classifi
accord
serotyp
base
phenotyp
characterist
howev
variant
rvc
current
assign
serotyp
method
vitro
cultur
success
date
crossneutr
properti
remain
unknown
rva
current
compris
differ
serotyp
rvb
type
base
genotyp
related
rvc
separ
least
geno
type
rv
small
nonenvelop
virus
approxim
nm
diamet
singlestrand
positivesens
rna
genom
approxim
kb
belong
genu
enteroviru
within
famili
picornavirida
genom
organ
rv
consist
untransl
region
utr
singl
open
read
frame
encod
singl
polyprotein
utr
polyadenyl
tract
fig
rvc
genet
divers
rv
speci
rvc
genom
shortest
among
report
rv
human
enterovirus
also
sever
uniqu
genet
element
distinguish
rvc
speci
first
identifi
respiratori
secret
patient
pneumonia
although
commonli
detect
respiratori
tract
sometim
stool
also
found
blood
cerebrospin
fluid
tonsillar
tissu
hbov
member
propos
genu
bocaparvoviru
famili
parvovirida
small
nonenvelop
icosahedr
virus
approxim
nm
diamet
singlestrand
dna
genom
contain
open
read
frame
orf
first
sequenti
orf
encod
nonstructur
protein
third
downstream
orf
encod
viral
capsid
protein
viru
replic
depend
host
cell
machineri
eg
dna
polymeras
addit
genotyp
identifi
human
stool
sampl
children
gastrointestin
ill
sinc
rare
detect
respiratori
specimen
data
link
gastroenter
conclus
associ
clinic
ill
date
human
case
mer
epidemiolog
link
middl
east
jordan
saudi
arabia
unit
arab
emir
qatar
fig
health
careassoci
famili
transmiss
document
merscov
close
relat
betacoronavirus
recov
bat
hong
kong
mexico
europ
africa
addit
serolog
studi
determin
dromedari
camel
oman
expos
merscov
possibl
link
camel
transmiss
cycl
adenoviru
speci
b
subdivid
speci
gener
associ
respiratori
diseas
wherea
member
speci
tend
infect
genitourinari
andor
respiratori
tract
adenovirus
transmit
respiratori
droplet
fecalor
rout
well
fomit
militari
recruit
highli
suscept
adenoviru
infect
includ
pneumonia
ard
like
attribut
crowd
numer
stressor
first
describ
outbreak
ard
militari
train
facil
netherland
rare
outbreak
describ
great
britain
uzbekistan
czechoslovakia
describ
case
outbreak
caus
sporad
case
describ
unit
state
militari
recruit
outbreak
occur
unit
state
militari
train
facil
landmark
outbreak
san
antonio
approxim
traine
infect
although
individu
sever
diseas
subsequ
detect
addit
militari
base
civilian
washington
oregon
alaska
wisconsin
pennsylvania
new
york
california
march
june
case
confirm
state
includ
hospit
intens
care
mortal
sequenc
virus
outbreak
ident
differ
viru
netherland
suggest
emerg
new
variant
like
cessat
adenoviru
vaccin
effort
us
militari
like
contribut
reemerg
adenovirusassoci
ard
militari
base
includ
diseas
similarli
rv
thought
rvc
transmit
person
person
direct
indirect
contact
aerosol
viru
infect
effici
initi
intranas
conjunctiv
inocul
rvc
detect
contin
throughout
world
often
show
season
pattern
infect
similar
identifi
rv
gener
high
incid
peak
earli
fall
late
spring
temper
subtrop
countri
raini
season
tropic
area
may
peak
winter
evenli
distribut
yearround
rva
rvc
often
cocircul
nearequival
proport
may
altern
common
rv
speci
differ
time
year
rvb
infect
typic
occur
less
frequent
overal
preval
rvc
publish
studi
adult
children
respiratori
symptom
rang
rvc
account
rv
test
differ
among
patient
group
specimen
type
detect
method
may
account
broad
rang
report
preval
region
commonli
use
genet
character
rv
clinic
sampl
recent
phylogenet
analys
suggest
nearli
full
region
sequenc
reliabl
separ
clade
utr
sequenc
alon
speci
determin
sometim
problemat
recombin
event
affect
region
use
molecular
date
analysi
sequenc
code
region
project
rvc
circul
least
year
estim
evolutionari
rate
substitut
per
site
per
year
mode
transmiss
larg
unknown
may
similar
parvovirus
transmit
variou
rout
includ
respiratori
urin
fecalor
seroepidemiolog
studi
indic
distribut
worldwid
individu
expos
often
earli
life
hbov
genotyp
may
also
distribut
global
seroepidemiolog
complic
crossreact
seroposit
common
infant
younger
month
owe
transfer
matern
antibodi
declin
increas
primari
infect
year
age
children
seroposit
preval
respiratori
infect
rang
mainli
children
younger
year
winter
spring
month
detect
infrequ
older
age
group
includ
adult
although
antibodi
estim
among
preval
virus
along
respiratori
syncyti
viru
rsv
rhinovirus
adenovirus
children
hospit
respiratori
diseas
howev
serolog
studi
shown
mere
presenc
dna
respiratori
tract
proof
acut
primari
infect
prolong
viral
shed
could
explain
studi
found
dna
frequent
asymptomat
symptomat
case
high
percentag
coinfect
dna
detect
stool
sampl
patient
without
gastroenter
respiratori
specimen
asymptomat
individu
individu
infect
merscov
typic
present
rapidli
progress
pneumonia
abnorm
chest
radiograph
rang
mild
extens
unilater
bilater
opac
addit
signific
number
case
also
present
develop
acut
renal
failur
case
seri
patient
indic
fever
cough
dyspnea
myalgia
gastrointestin
symptom
also
note
diarrhea
vomit
abdomin
pain
interestingli
patient
comorbid
includ
diabet
hypertens
chronic
heart
diseas
chronic
renal
diseas
mortal
rate
mer
approxim
much
higher
mortal
report
sar
casefat
rate
appear
increas
age
mild
asymptomat
case
also
identifi
bring
full
spectrum
diseas
caus
merscov
question
similar
primarili
caus
febril
respiratori
ill
fri
outbreak
set
fri
defin
fever
f
plu
one
sign
respiratori
ill
diagnosi
pneumonia
common
present
report
pneumonia
case
pharyngoconjunctiv
fever
caus
also
report
one
militaryassoci
outbreak
found
common
emerg
respiratori
virus
influenza
symptom
infect
cough
sputum
product
chill
dyspnea
sore
throat
nausea
chest
radiograph
typic
show
patchi
interstiti
infiltr
occasion
case
lobar
consolid
patient
white
blood
cell
count
typic
normal
although
neutrophil
monocyt
predomin
note
primari
risk
factor
militari
train
although
one
outbreak
also
demonstr
smoke
advanc
age
year
alaskan
nativ
heritag
risk
factor
like
respiratori
virus
clinic
syndrom
associ
rvc
rang
mild
even
asymptomat
infect
acut
lower
respiratori
tract
ill
includ
pneumonia
recurr
wheez
bronchiti
rvc
detect
patient
acut
ill
upper
respiratori
tract
lower
respiratori
tract
wheez
bronchiol
asthma
exacerb
exacerb
chronic
obstruct
pulmonari
diseas
pneumonia
common
cold
flulik
ill
pharyng
crouplik
cough
rhiniti
nasal
congest
bronchiti
dyspnea
nonrespiratori
symptom
rvcposit
patient
includ
fever
febril
convuls
otiti
media
pericard
poor
appetit
appar
lifethreaten
event
data
suggest
rvc
frequent
detect
older
children
rva
rvc
detect
blood
sampl
children
sever
respiratori
infect
viremia
associ
significantli
higher
concentr
viru
nasopharynx
fact
higher
rvc
viral
load
respiratori
specimen
associ
sever
upper
lower
respiratori
tract
diseas
median
peak
viral
load
patient
rvc
infect
shown
higher
patient
rva
rvb
infect
stool
specimen
also
reveal
presenc
rvc
rv
speci
viral
load
compar
enterovirus
sometim
along
gastrointestin
pathogen
clinic
signific
rv
fecal
sampl
remain
unclear
patient
hospit
dissemin
diseas
rvc
detect
respiratori
stool
pericardi
effus
urin
plasma
specimen
health
careassoci
outbreak
respiratori
infect
attribut
rvc
neonat
intens
care
unit
longterm
care
facil
sever
studi
demonstr
clinic
signific
differ
among
patient
infect
rvc
comparison
infect
rv
speci
differ
prevail
acut
upper
lower
respiratori
tract
infect
wheez
asthma
cystic
fibrosi
exacerb
hand
investig
report
signific
differ
rvc
rva
respect
diseas
manifest
confound
issu
fact
rvc
may
found
coinfect
respiratori
virus
case
nevertheless
evidenc
case
rvc
monoinfect
speci
contribut
substanti
respiratori
tract
infect
mani
requir
hospit
clinic
manifest
respiratori
tract
infect
rang
mild
upper
respiratori
diseas
sever
lifethreaten
pneumonia
howev
direct
impact
infect
respiratori
tract
often
difficult
assess
frequent
detect
asymptomat
children
coinfect
respiratori
virus
symptomat
children
rate
respiratori
sampl
mani
studi
demonstr
posit
correl
respiratori
ill
high
copi
number
dna
presenc
monoinfect
monoinfect
associ
higher
viral
load
coinfect
likewis
detect
viremia
distinctli
associ
respiratori
symptom
asymptomat
individu
infect
patient
viremia
serolog
evid
acut
infect
high
copiesml
viral
load
mrna
respiratori
secret
andor
monoinfect
includ
pneumonia
tabl
report
sever
respiratori
diseas
found
signific
associ
otherwis
unexplain
lower
respiratori
tract
infect
children
may
caus
enceph
lifethreaten
complic
detect
tonsillar
lymphocyt
adenoid
pediatr
patient
suggest
role
pathogenesi
chronic
tonsillar
diseas
compar
virus
known
caus
respiratori
ill
young
children
patient
monoinfect
may
older
rsv
human
metapneumoviru
infect
studi
monoinfect
associ
shorter
durat
hospit
higher
creactiv
protein
level
white
blood
cell
count
lower
clinic
sever
score
less
frequent
hypoxia
compar
rsvmonoinfect
patient
tabl
cell
culturebas
experi
shown
merscov
receptor
differ
one
use
sarscov
identifi
dipeptidyl
peptidas
interact
viral
protein
merscov
also
appear
broader
host
rang
sarscov
infect
human
primat
porcin
bat
cell
line
yet
small
anim
model
merscov
infect
pathogenesi
fulli
elucid
howev
viral
antigen
local
ciliat
bronchial
epithelium
uncili
cell
termin
bronchi
merscov
replic
also
demonstr
type
type
ii
pneumocyt
thu
appear
merscov
affect
alveoli
ga
exchang
well
surfact
product
tissu
repair
tissu
tropism
adenoviru
vari
speci
serotyp
thought
mediat
specif
fiberreceptor
interact
speci
c
e
speci
b
virus
infect
respiratori
tract
speci
b
virus
infect
urinari
tract
speci
f
replic
gastrointestin
tract
speci
eye
belong
speci
along
predilect
respiratori
epithelium
replic
respiratori
epithelium
lead
cell
death
host
howev
clear
whether
cytopath
effect
adenoviru
due
viral
pathogenesi
host
immun
respons
adenovirus
also
evad
host
immun
respons
inhibit
interferon
activ
apoptosi
express
major
histocompat
complex
class
immunomodulatori
function
may
also
play
role
develop
latenc
persist
adenoviru
speci
name
speci
c
earli
experi
shown
rv
rel
low
optim
temperatur
growth
c
may
reflect
adapt
human
nasopharynx
emerg
respiratori
virus
influenza
associ
upper
respiratori
tract
infect
howev
later
experi
determin
minim
differ
replic
capac
c
c
sever
rv
rv
shown
replic
nasal
epithelium
nasopharynx
unlik
influenza
viru
rsv
caus
destruct
cytopatholog
upper
respiratori
tract
lower
respiratori
tract
rv
shown
caus
chang
interstiti
alveolar
process
inflammatori
find
rvb
rva
variant
use
intracellular
adhes
molecul
receptor
cell
entri
wherea
subset
rva
type
use
lowdens
lipoprotein
receptor
receptor
use
rvc
type
current
unknown
predict
capsid
structur
rvc
differ
significantli
rva
rvb
particularli
region
relat
receptor
antivir
bind
footprint
rvc
grow
typic
cellcultur
line
recent
grown
vitro
use
sinu
mucos
tissu
fulli
differenti
human
airway
epitheli
cell
viru
appear
use
cellular
receptor
distinct
rva
rvb
gener
shed
rvc
extend
beyond
week
resolut
symptom
immunocompromis
patient
may
shed
viru
extend
period
like
rvc
difficult
cultiv
vitro
definit
anim
model
infect
establish
thu
mechan
viru
replic
relat
host
immun
respons
remain
larg
unknown
studi
children
pneumonia
acut
wheez
asthma
bronchiol
suggest
abl
infect
lower
airway
bronchiol
patient
infect
may
system
viral
dna
detect
blood
cerebrospin
fluid
recent
cultur
differenti
human
airway
epitheli
cell
document
product
infect
caus
cytopathogenesi
apic
basolater
infect
cultur
epitheli
cell
result
disrupt
tight
junction
barrier
loss
cilia
cell
hypertrophi
recent
studi
impli
hbov
dna
exist
episom
infect
human
tissu
like
establish
persist
infect
host
current
known
whether
repres
latent
state
reactiv
detect
frequent
tonsillar
adenoid
tissu
suggest
lymphat
tissu
might
repres
site
persist
infect
well
sinu
mucos
tissu
dna
detect
month
serial
nasopharyng
specimen
otherwis
healthi
infant
young
children
respiratori
sampl
month
immunocompromis
pediatr
patient
prolong
replic
passiv
persist
may
account
frequent
presenc
symptomat
asymptomat
children
vrti
diagnosi
specif
caus
made
base
sole
clinic
sign
symptom
establish
viral
etiolog
infect
highli
depend
appropri
accur
diagnost
method
mani
newli
identifi
emerg
virus
preval
infect
may
histor
underestim
owe
lack
sensit
detect
method
merscov
cultur
vero
cell
cultur
although
commerci
avail
reagent
avail
identifi
merscov
viru
posit
cultur
furthermor
commerci
avail
molecular
test
even
detect
human
cov
detect
merscov
howev
center
diseas
control
prevent
cdc
develop
valid
laboratorydevelop
molecular
test
detect
merscov
food
drug
administr
fda
issu
emerg
use
author
cdc
realtim
revers
transcriptas
rt
pcr
assay
test
distribut
laboratori
respons
network
aid
identif
potenti
case
unit
state
definit
confirm
mer
case
requir
posit
rtpcr
test
least
specif
merscov
target
posit
singl
target
test
sequenc
second
target
respiratori
infect
caus
adenoviru
gener
diagnos
use
direct
fluoresc
antigen
detect
dfa
viral
cultur
nucleic
acid
amplif
test
naat
sever
fdaclear
naatbas
test
includ
adenoviru
detect
current
avail
dfa
cultur
naat
wide
rang
report
sensit
larg
number
serotyp
genet
heterogen
seen
among
adenovirus
naat
describ
gener
use
epidemiolog
studi
rv
best
identifi
rtpcr
target
utr
perform
respiratori
secret
infect
individu
although
rel
highli
conserv
comparison
rv
code
region
sequenc
variat
utr
differ
rv
type
creat
difficulti
design
primer
pair
satisfactorili
detect
rv
type
speci
specif
identif
rv
use
rtpcr
target
utr
also
complic
fact
enteroviru
detect
assay
often
crossreact
rv
sequenc
similar
region
high
sensit
pcr
also
limit
presenc
viral
nucleic
acid
respiratori
secret
patient
respiratori
symptom
necessarili
connot
causal
rvc
rv
identifi
rtpcr
respiratori
specimen
high
proport
asymptomat
individu
possibl
lead
overestim
diseas
burden
howev
one
studi
includ
asymptomat
control
identifi
rvc
often
sick
well
patient
rv
detect
asymptomat
individu
also
evid
rvc
may
interfer
infect
virus
codetect
multipl
virus
respiratori
infect
seen
frequent
result
increas
avail
multiplex
microarray
detect
assay
high
codetect
rate
also
add
difficulti
differenti
rvc
true
pathogen
report
indic
correl
higher
viral
load
symptomat
diseas
howev
quantit
rtpcr
test
readili
avail
standard
quantif
rv
type
gener
accur
viral
load
test
respiratori
specimen
challeng
variou
type
sampl
collect
techniqu
patient
popul
assess
identif
infect
speci
serotyp
import
diagnost
detect
mix
infect
reinfect
differ
rv
serotyp
well
broader
clinic
investig
relationship
serotyp
speci
diseas
sever
epidemiolog
investig
circul
turnov
rv
readili
detect
pcr
assay
target
ns
np
vp
gene
howev
shed
respiratori
secret
week
month
follow
primari
infect
detect
asymptomat
individu
detect
antibodi
serum
addit
dna
detect
differenti
primari
infect
longterm
postinfecti
shed
serolog
method
develop
detect
immunoglobulin
ig
igg
antibodi
use
recombin
capsid
antigen
viruslik
particl
known
antibodi
crossreact
antigen
reliabl
detect
respons
may
best
achiev
deplet
reactiv
antibodi
genotyp
iggavid
enzym
immunoassay
use
distinguish
acut
past
infect
primari
secondari
infect
although
antigen
crossreact
may
occur
detect
dna
blood
close
associ
symptom
posit
respiratori
sampl
alon
higher
viral
load
respiratori
specimen
correl
acut
infect
fewer
coinfect
increas
diseas
sever
therefor
acut
infect
accur
made
detect
dna
serum
high
viral
load
copiesml
respiratori
sampl
along
detect
igm
antibodi
increas
igg
respons
pair
serum
sampl
overcom
ambigu
limit
qualit
dna
detect
respiratori
specimen
also
shown
presenc
mrna
ie
activ
transcrib
viru
like
indic
caus
role
viru
acut
respiratori
tract
diseas
treatment
prognosi
mani
respiratori
virus
definit
treatment
covassoci
ill
gener
need
owe
mild
natur
cov
infect
eg
howev
sever
diseas
increas
mortal
caus
sarscov
merscov
demonstr
need
antivir
option
combin
ribavirin
shown
reduc
viral
replic
moder
host
immunolog
respons
improv
outcom
rhesu
macaqu
infect
merscov
addit
vitro
data
demonstr
ribavirin
interferona
interferonb
mycophenol
acid
activ
merscov
howev
mani
drug
nephrotox
may
appropri
choic
patient
infect
merscov
also
caus
acut
renal
failur
although
specif
treatment
exist
adenoviru
cidofovir
ribavirin
show
vitro
activ
well
limit
clinic
efficaci
cidofovir
acycl
nucleosid
phosphat
activ
sever
dna
virus
ribavirin
nucleosid
analogu
broad
antivir
properti
clinic
data
efficaci
conflict
owe
pauciti
clinic
efficaci
data
side
effect
treatment
offlabel
use
either
drug
adenoviru
treatment
gener
reserv
dissemin
emerg
respiratori
virus
influenza
infect
immunocompromis
patient
treatment
ard
immunocompet
patient
gener
support
natur
live
attenu
vaccin
approv
use
militari
recruit
age
year
enter
basic
train
may
provid
crossprotect
adenoviru
serotyp
specif
antivir
treatment
rvc
infect
therapi
support
respiratori
viru
infect
vaccin
success
develop
virus
rv
primarili
due
numer
serotyp
limit
crossprotect
serotyp
rvc
standard
precaut
taken
limit
transmiss
respiratori
secret
novel
virus
continu
discov
surveil
program
applic
new
molecular
techniqu
moreov
new
introduct
virus
area
never
previous
detect
repres
challeng
diagnost
virolog
laboratori
date
mer
epidem
local
middl
east
howev
merscov
second
cov
emerg
major
human
respiratori
pathogen
last
year
studi
need
ascertain
full
scope
diseas
epidemiolog
risk
factor
research
aim
refin
pathogenesi
merscov
import
inform
potenti
chemotherapi
intervent
strategi
although
much
learn
sar
epidem
merscov
belong
differ
lineag
appear
pathogen
surveil
effort
need
continu
identifi
novel
coronavirus
bat
potenti
host
earli
detect
novel
virus
includ
coronavirus
import
strategi
limit
spread
newli
emerg
virus
combin
immunolog
popul
emerg
adenoviru
greater
virul
transmiss
led
militari
civilian
outbreak
involv
clear
caus
outbreak
respiratori
diseas
larg
recogniz
sever
diseas
increas
pneumonia
mortal
mild
respiratori
infect
attribut
may
go
undiagnos
either
lack
test
altogeth
lack
typespecif
test
therefor
import
continu
surveil
effort
includ
adenoviru
serotyp
assess
full
spectrum
diseas
recent
vrti
infant
young
children
attribut
establish
pathogen
rsv
parainfluenza
viru
adenoviru
evid
newli
identifi
speci
rvc
virus
signific
respiratori
pathogen
young
children
rvc
detect
sometim
passeng
sometim
pathogen
acut
respiratori
tract
diseas
monoinfect
associ
high
rate
morbid
pathogen
role
challeng
diagnosi
acut
infect
use
combin
method
includ
pcr
blood
quantit
pcr
detect
mrna
respiratori
secret
serolog
demonstr
respons
signific
amount
respiratori
tract
diseas
young
children
abil
newer
diagnost
assay
simultan
detect
multipl
respiratori
virus
includ
newli
identifi
one
help
clarifi
virushost
interact
still
partial
unknown
elucid
appropri
infect
control
measur
monitor
respiratori
outbreak
accur
time
diagnosi
viral
infect
key
optim
patient
manag
appropri
use
antivir
reduc
unnecessari
test
superflu
antibiot
implement
infect
control
precaut
identif
dunn
miller
genotyp
novel
viral
pathogen
also
affect
public
health
initi
aim
curtail
widespread
outbreak
